News

Vanda Pharmaceuticals Set to Reveal Q4 and Year-End Results Soon

Vanda Pharmaceuticals Set to Reveal Q4 and Year-End Results Soon

Vanda Pharmaceuticals Announces Upcoming Financial Results

Vanda Pharmaceuticals Inc. (Vanda) has declared exciting news regarding its financial performance. The company will unveil its fourth quarter and full year 2024 financial results. This announcement is set for mid-February, after the market closes, which allows investors and analysts to promptly digest the important information.

Details of the Financial Announcement

The anticipated release of Vanda's financial results on a Thursday afternoon signals a key moment for the company. Investors can expect insights into the overall performance of the business and an analysis of revenue growth, which is crucial for understanding Vanda's market position.

Conference Call to Discuss Results

In conjunction with the results announcement, Vanda Pharmaceuticals will facilitate a conference call. Scheduled for 4:30 PM ET on the same day, the call will be led by management, who will share insights not only about the financial results but also about other pivotal corporate developments.

Participation in the Conference Call

To engage in this conference call, participants can dial specific numbers depending on their location. Domestic callers can use 1-800-715-9871, while international callers are encouraged to call 1-646-307-1963. It is essential to note the passcode for entry, which is 2881765.

Accessing the Call Online

For those who prefer digital access, the conference call will be streamed online, making it easy for investors to listen in. Vanda encourages participants to log onto their website ahead of time to ensure a seamless experience—advising attendees to arrive at least 15 minutes early to prepare.

Replay Availability After the Call

Understanding that not everyone may be able to attend live, Vanda Pharmaceuticals will also provide a recording of the conference call. This replay will be available shortly after the call concludes, accessible from the late evening of the announcement day until late the following week.

Replay Call-In Number

Callers can use the same passcode (2881765) to access the replay, with dedicated lines for both domestic and international listeners. Domestic callers can use 1-800-770-2030, and international callers can reach 1-609-800-9909.

About Vanda Pharmaceuticals

As a notable biopharmaceutical company, Vanda Pharmaceuticals is substantially focused on developing groundbreaking therapies. Their mission encompasses addressing significant medical needs to enhance patient experiences and health outcomes. With an innovative streak, Vanda is committed to advancing healthcare through its specialized research and development efforts.

Continued Commitment to Innovation

Vanda's resolve to innovate showcases its dedication to enhancing treatments that meet patient demands. By pushing the envelope in drug development, they continue to find solutions where there previously may have been few. The firm’s ongoing efforts in this sector solidify its reputation as a leader in biopharmaceuticals.

Corporate Contact Information

For inquiries, Vanda has a dedicated communications team ready to assist. Kevin Moran serves as the Senior Vice President, Chief Financial Officer, and Treasurer. His expertise and leadership are vital in steering the company's financial landscape.

Connect with Vanda Pharmaceuticals

For further information, you can find Vanda Pharmaceuticals on various platforms and their official website. Keeping an eye on their communications ensures that stakeholders stay well-informed about any new developments or breakthroughs.

Frequently Asked Questions

When will Vanda Pharmaceuticals announce its financial results?

Vanda Pharmaceuticals will announce its financial results for Q4 and the full year 2024 on February 13, 2025.

How can I participate in the conference call?

To participate, you can call 1-800-715-9871 for domestic access or 1-646-307-1963 for international callers using the passcode 2881765.

Will the conference call be available for replay?

Yes, there will be a replay available starting at 8:30 PM ET on the announcement day until 11:59 PM ET on February 20, 2025.

Who can I contact for more information about Vanda?

Kevin Moran, the CFO of Vanda Pharmaceuticals, is the primary contact for inquiries related to the company's financials.

What is Vanda Pharmaceuticals focused on?

Vanda Pharmaceuticals is committed to developing innovative therapies that address significant medical needs to improve patient outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 187

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 5

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading
DemandTec Leads the Pack in Retail Pricing Arena

Updated Category News Views 46

DemandTec's Climb to Retail Pricing Stardom The news hitting the streets is that DemandTec's carved out a top spot in QKS Group's SPARK Matrix™ for Intelligent Retail Pricing & Promotion Optimization for 2026. In an industry filled with slick operators and gimmicks, it takes some real chops to stand out. They've clinched this position by rolling out a platform that ties...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 131

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Parallels Desktop Tops 2026 Picks for Windows on Mac

Updated Category News Views 59

Diving into the Cross-Platform Conundrum Now, I've been in the trenches long enough to know that when companies start relying on Mac computers but can't ditch their essential Windows apps, they're bound to hit a digital brick wall. Picture this—accounting, enterprise management, all that jazz that still needs Windows to function. For those jumping between these two...

Continue Reading
Insight Into Midland TX Real Estate Sales Timing

Updated Category News Views 0

How Fast Do Homes Move in Midland? This ain't my first rodeo predicting the real estate rollercoaster in Texas. Midland's housing market is one nifty beast—homes can either sell like hotcakes or just sit gathering dust. You got HelloNation pulling in DeLaura Gammage, a pro who knows the terrain like the back of her hand, to spell out the why and how long it'll take to...

Continue Reading
Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 35

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 67

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 117

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Plumas Bancorp Increases Shareholder Value with Dividend

Updated Category News Views 100

Plumas Bancorp Announces Quarterly Cash Dividend Plumas Bancorp (Nasdaq: PLBC), the parent company of Plumas Bank, has recently made an important announcement regarding its financial strategy. The Board of Directors has declared a regular quarterly cash dividend of $0.30 per share on common stock, as a testament to the company's ongoing commitment to delivering value to...

Continue Reading
DTE Energy's Junior Subordinated Debentures Offer: Key Insights

Updated Category News Views 168

DTE Energy's Junior Subordinated Debentures Introduction DTE Energy Company (NYSE: DTE) has made a significant announcement regarding its financial strategies through the pricing of its 2025 Series H 6.25% Junior Subordinated Debentures. This offering, valued at $600 million in aggregate principal, is designed for various financial maneuvers that could solidify DTE's...

Continue Reading
Key Insights on SCOR's Share Capital and Voting Rights Details

Updated Category News Views 294

Understanding SCOR's Recent Share Capital Declaration On a notable date, SCOR made a significant announcement regarding its share capital. The communication was essential for understanding the current status of total shares and voting rights. As a leading global reinsurer, SCOR's declarations provide crucial insights into its financial health and operational metrics....

Continue Reading
Enthusiast Gaming's Record-Breaking Spectacle at Luminosity Event

Updated Category News Views 100

Enthusiast Gaming's Luminosity Invitational Shines Bright Enthusiast Gaming Holdings Inc. ('Enthusiast Gaming' or the 'Company'), a dynamic leader in the gaming and media sector, has made waves recently with its spectacular Luminosity Invitational: Back 2 School. This thrilling Super Smash Bros Ultimate event drew in a staggering estimate of over 400,000 unique online...

Continue Reading
UAB Kvartalas Closes Subscription Early for Latest Bonds

Updated Category News Views 128

UAB Kvartalas Closes Subscription for 4th Tranche of Bonds UAB "Kvartalas", a legal entity committed to facilitating growth and innovation, has made a significant announcement regarding its bond issuance process. The company, registered with the legal code 305475438, has its headquarters situated at Jogailos St. 4, Vilnius, Republic of Lithuania. In response to...

Continue Reading